NCT03395509View on ClinicalTrials.gov

The Intersectional Viborg Screening Program: Cost-(Effectiveness) of Screening for Diabetes and Cardiovascular Diseases

Enrolling by invitationOBSERVATIONAL
Enrollment

4,500

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2029

Conditions
AgingAortic Aneurysm, AbdominalHypertensionMass ScreeningPeripheral Arterial DiseaseArrythmiaDiabetesCarotid Atherosclerosis
Trial Locations (1)

8800

Cardiovascular research Center (KVC), Viborg Hospital, Viborg

All Listed Sponsors
collaborator

Odense University Hospital

OTHER

lead

Central Jutland Regional Hospital

OTHER